Researchers develop RETFound, an AI tool capable of predicting the risk of ocular diseases, heart failure, Parkinson's disease, and more based on retinal images
I'm learning so much every day.🙏🏻 👁 RETFound is the 1st open-source foundation model for retinal imaging—diagnosing eye diseases... Eric Topol / @erictopol : Just published @Nature 1st major large language model in medicine Self-supervised #AI of 2 million retina images to predict many diseases beyond the eye, such as heart attack, stroke, heart failure, Parkinson's disease https://www.nature.com/... led by @pearsekeane @Yukunzhou19 [image] Forums: r/science : AI detects eye disease and risk of Parkinson's from retinal images
Context & Ripple Effects
Retinal-image AI had already been explored through DeepMind’s NHS eye-scan project and Verily’s work inferring cardiovascular risk factors from retinal scans. RETFound packages that line of research into an open-source foundation model rather than a single narrowly defined task.
The story matters because it extends retinal imaging from detecting eye conditions toward estimating risks associated with diseases elsewhere in the body. That broadens the potential research utility of a routine imaging modality, while leaving clinical validation and deployment as separate steps.
First-order effects
- Researchers and developers can use RETFound as a shared pretrained starting point for retinal-imaging models, reducing the need to build a model from scratch for each target condition.
- The model creates a common research asset for testing whether retinal signals can support risk prediction across ocular, cardiovascular and neurological conditions; it does not by itself establish a clinical diagnostic workflow.
Second-order effects
- Developers of single-purpose retinal tools face pressure to show whether specialized models outperform or complement a reusable foundation model, particularly on clinically meaningful validation tasks.
- Health systems and regulators considering such tools will need to distinguish research risk scores from cleared diagnostic use, a boundary underscored by the earlier FDA-cleared autonomous diabetic-retinopathy device.
Third-order effects
- If foundation models generalize reliably across retinal tasks, retinal imaging could increasingly become a platform for multi-condition screening research rather than a collection of isolated eye-disease algorithms.
- That shift would make dataset provenance, external validation and public-safety oversight more central, since one model’s outputs could influence multiple clinical use cases.
The trend: RETFound is part of the move from disease-specific medical AI toward reusable foundation models trained on large clinical data modalities.